ORAMED PHARMACEUTICALS INC (ORMP) Institutional Shareholders

ORAMED PHARMACEUTICALS INC (ORMP) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $80.66M in ORMP holdings during the latest filing period.

Mercer Global Advisors Inc is currently the largest disclosed institutional shareholder of ORMP tracked by InsiderSet, reporting ownership valued at approximately $18.33M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $18.06M, representing an estimated loss of -1.46% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 81% of the total disclosed ORMP value among the investors covered in this analysis. Major shareholders include Mercer Global Advisors Inc, Aquamarine Financial (Cayman) Ltd, Gem Investment Advisors, Llc, and several other long-term asset managers with concentrated positions in ORAMED PHARMACEUTICALS INC (ORMP).

This page ranks the largest institutional ORMP shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

84

Total Reported Value

$80.66M

Largest Holder

Mercer Global Advisors Inc

Largest Position

$18.33M

Insider Transactions (90d)

3

Latest Filing Quarter

Q2 2026

New Institutional Positions

99

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Mercer Global Advisors Inc0.02%3,810,540$18,328,697$18,061,960-$266,737-1.46%
Aquamarine Financial (Cayman) Ltd0.67%2,512,175$12,083,562$11,907,710-$175,853-1.46%
Gem Investment Advisors, Llc5.90%1,998,802$9,614,238$9,474,321-$139,917-1.46%
Blackrock, Inc.0.00%1,608,111$7,735,015$7,622,446-$112,569-1.46%
Murchinson Ltd.3.00%1,290,294$6,206,314$6,115,994-$90,320-1.46%
Bml Capital Management, Llc2.38%866,269$4,166,754$4,106,115-$60,639-1.46%
Boothbay Fund Management, Llc0.05%578,638$2,783,249$2,742,744-$40,505-1.46%
Geode Capital Management, Llc0.00%500,690$2,408,318$2,373,271-$35,047-1.46%
Goldman Sachs Group Inc0.00%253,293$1,218,339$1,200,609-$17,730-1.46%
State Street Corp0.00%242,100$1,164,501$1,147,554-$16,947-1.46%
Rathbones Group Plc0.00%233,018$1,120,816$1,104,505-$16,311-1.46%
Vanguard Portfolio Management Llc0.00%229,882$1,105,732$1,089,641-$16,091-1.46%
Dimensional Fund Advisors Lp0.00%202,609$973,782$960,367-$13,415-1.38%
Northern Trust Corp0.00%184,920$889,465$876,521-$12,944-1.46%
Renaissance Technologies LLCJim Simons0.00%183,800$884,078$871,212-$12,866-1.46%
Wells Fargo & Company/Mn0.00%166,000$798,458$786,840-$11,618-1.46%
Bank Of America Corp0.00%150,694$724,838$714,290-$10,548-1.46%
Strs Ohio0.00%133,800$643,578$634,212-$9,366-1.46%
Jane Street Group, Llc0.00%113,349$545,209$537,274-$7,935-1.46%
O'Shaughnessy Asset Management, Llc0.00%102,962$495,247$488,040-$7,207-1.46%
Marshall Wace, Llp0.00%101,953$490,393$483,257-$7,136-1.46%
Hrt Financial Lp0.00%97,582$469,000$462,539-$6,461-1.38%
Hillsdale Investment Management Inc.0.01%89,300$429,533$423,282-$6,251-1.46%
Ritholtz Wealth Management0.01%84,347$405,709$399,805-$5,904-1.46%
Charles Schwab Investment Management Inc0.00%83,634$402,280$396,425-$5,855-1.46%
Bank Of New York Mellon Corp0.00%79,255$381,217$375,669-$5,548-1.46%
Ubs Group Ag0.00%67,671$325,498$320,761-$4,737-1.46%
American Century Companies Inc0.00%59,775$287,518$283,334-$4,185-1.46%
Xtx Topco Ltd0.00%49,923$240,130$236,635-$3,495-1.46%
Nuveen, Llc0.00%46,404$223,203$219,955-$3,248-1.46%
Morgan Stanley0.00%43,357$208,547$205,512-$3,035-1.46%
Citadel Advisors Llc0.00%41,565$199,927$197,018-$2,909-1.45%
Deutsche Bank Ag\0.00%33,198$159,682$157,359-$2,323-1.46%
Prelude Capital Management, Llc0.01%32,713$157,350$155,060-$2,290-1.46%
Bailard, Inc.0.00%32,478$156,219$153,946-$2,273-1.46%
Rhumbline Advisers0.00%30,621$147,281$145,144-$2,137-1.45%
Algert Global Llc0.00%28,958$139,288$137,261-$2,027-1.46%
Price T Rowe Associates Inc0.00%27,909$135,000$132,289-$2,711-2.01%
Connor, Clark & Lunn Investment Management Ltd.0.00%25,207$121,246$119,481-$1,765-1.46%
Invesco Ltd.0.00%24,751$119,052$117,320-$1,732-1.46%
Susquehanna International Group, Llp0.00%22,300$107,263$105,702-$1,561-1.46%
Millennium Management Llc0.00%21,861$105,151$103,621-$1,530-1.45%
Pnc Financial Services Group, Inc.0.00%21,200$101,972$100,488-$1,484-1.46%
Redwood Family Wealth Llc0.09%20,745$99,783$98,331-$1,452-1.45%
Sage Capital Management, Llc0.03%17,977$86,474$85,211-$1,263-1.46%
Citigroup Inc0.00%15,808$76,037$74,930-$1,107-1.46%
Mirae Asset Global Etfs Holdings Ltd.0.00%15,671$75,378$74,281-$1,097-1.46%
Vanguard Fiduciary Trust Co0.00%14,098$67,811$66,825-$986-1.45%
Jpmorgan Chase & Co0.00%14,158$65,693$67,109+$1,416+2.16%
Y-Intercept (Hong Kong) Ltd0.00%12,817$61,650$60,753-$897-1.46%
Showing 50 of 84

Frequently asked questions about ORMP

  • Who owns the most ORMP stock?

    The largest holders of ORMP are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ORAMED PHARMACEUTICALS INC (ORMP).

  • Is ORMP widely held by superinvestors?

    Many widely followed stocks like ORMP appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ORMP is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.